K284-1314 Screening compound: methyl 2-{[(benzylcarbamoyl)methyl]sulfanyl}-4-oxo-3-[2-(4-sulfamoylphenyl)ethyl]-3,4-dihydroquinazoline-7-carboxylate

K284-1314 Screening compound: methyl 2-{[(benzylcarbamoyl)methyl]sulfanyl}-4-oxo-3-[2-(4-sulfamoylphenyl)ethyl]-3,4-dihydroquinazoline-7-carboxylate
K284-1314 Screening compound: methyl 2-{[(benzylcarbamoyl)methyl]sulfanyl}-4-oxo-3-[2-(4-sulfamoylphenyl)ethyl]-3,4-dihydroquinazoline-7-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound K284-1314
methyl 2-{[(benzylcarbamoyl)methyl]sulfanyl}-4-oxo-3-[2-(4-sulfamoylphenyl)ethyl]-3,4-dihydroquinazoline-7-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K284-1314

Molecular Formula

C27H26N4O6S2 (C27 H26 N4 O6 S2)

Compound Name

methyl 2-{[(benzylcarbamoyl)methyl]sulfanyl}-4-oxo-3-[2-(4-sulfamoylphenyl)ethyl]-3,4-dihydroquinazoline-7-carboxylate

IUPAC name

methyl 2-{[(benzylcarbamoyl)methyl]sulfanyl}-4-oxo-3-[2-(4-sulfamoylphenyl)ethyl]-34-dihydroquinazoline-7-carboxylate

SMILES

COC(c(cc1)cc(N=C(N2CCc(cc3)ccc3S(N)(=O)=O)SCC(NCc3ccccc3)=O)c1C2=O)=O

InChI

InChI=1S/C27H26N4O6S2/c1-37-26(34)20-9-12-22-23(15-20)30-27(38-17-24(32)29-16-19-5-3-2-4-6-19)31(25(22)33)14-13-18-7-10-21(11-8-18)39(28,35)36/h2-12,15H,13-14,16-17H2,1H3,(H,29,32)(H2,28,35,36)

InChI Key

RNMNQXTVLPFYRA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD04421626

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

566.66

Hydrogen Bond Acceptors Count

14.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.598

Distribution Coefficient, logD

2.597

Water Solubility, LogSw

-3.35

Polar Surface Area

121.998

Acid Dissociation Constant (pKa)

10.18

Base Dissociation Constant (pKb)

0.66

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.50

K284-1314 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with K284-1314 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K284-1314?
Check Price and Availability of K284-1314, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K284-1314 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K284-1314
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K284-1314
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K284-1314 available by request